Regulus Therapeutics (NASDAQ: RGLS) Stock Skyrockets 70% – What’s The Buzz?
Regulus Therapeutics (NASDAQ: RGLS) stock soared over 70% on Tuesday after the company reported positive phase 1b ADPKD trial results. […]
Regulus Therapeutics (NASDAQ: RGLS) Stock Skyrockets 70% – What’s The Buzz? Read More »